Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 101 - 150 out of 99,004

Document Document Title
WO/2017/170418A1
The present invention provides art for producing, from a polypeptide expression system having yeast as a host, a wild-type endonuclease variant polypeptide derived from Serratia marcescens. This polypeptide: (a) includes an amino acid se...  
WO/2017/170849A1
The present application provides a naïve pluripotential stem cell culturing medium for efficiently proliferating naïve pluripotent stem cells while maintaining the non-differentiation and pluripotency (multipotency) thereof. The medium...  
WO/2017/172996A1
Disclosed herein are polynucleotides and the polypeptides encoded thereby and their use to increase biomass production by photosynthetic organisms. Also provided are photosynthetic organisms transformed by such polynucleotides and expres...  
WO/2017/170468A1
The present invention addresses the problem of providing a novel means for increasing the secretion amounts of an intrinsic protein and a heterologous protein. The present invention solves this problem by means of: a vector which include...  
WO/2017/169399A1
Provided are a microorganism which can efficiently produce protocatechuic acid or a salt thereof using a sugar as a raw material, and a method for efficiently producing protocatechuic acid or a salt thereof using the microorganism. The m...  
WO/2017/169783A1
The present invention provides a method for determining a dosage of Daikenchuto, a method for predicting the efficacy of Daikenchuto, etc. using an objective index. The method for predicting the efficacy of Daikenchuto in a patient is ch...  
WO/2017/171098A1
A mutant carotenoid-producing bacterium that includes a gene set forth in any of (a) to (c). (a) A gene of a carotenoid-producing bacterium, which codes for a protein that includes a mutant amino acid sequence in which at least the 225...  
WO/2017/164275A1
The purpose of the present invention is to provide a novel composition for improving an oral cavity environment. According to the present invention, a composition for improving an oral cavity environment, which composition contains a fer...  
WO/2017/163144A1
The present disclosure provides genetically modified Chlorella sorokiniana. DAD1 gene is overexpressed in wild type Chlorella sorokiniana to obtain the genetically modified Chlorella sorokiniana. The genetically modified Chlorella soroki...  
WO/2017/163946A1
Provided is an induction-type promoter which acts in a transformant obtained by using a yeast belonging to the genus Schizosaccharomyces as a host and which is capable of inducing expression by adding a specific substance to a culture me...  
WO/2017/165244A1
Microorganisms and bioprocesses are provided that convert gaseous C1 containing substrates, such as syngas, producer gas, and renewable H2 combined with CO2, into nutritional and other useful bioproducts.  
WO/2017/161917A1
System and method of cultivating Cordyceps, specifically provided herein is a system of cultivating Cordyceps comprising: a Helpialus moth trapping device (100); a Hepialus moth eggs screening device (200), wherein the device is connecte...  
WO/2017/163463A1
[Problem] To provide an automatable cell acquisition technique by which a plurality of cells can be simultaneously analyzed while reducing the frequencies of false positives and false negatives. [Solution] A cell sorter or flow cytometer...  
WO/2017/162090A1
Provided is a recombinant hansenula-based high dosage hepatitis B vaccine, an HBsAg pure product (stock solution) yield of a recombinant hansenula fermentation broth used for producing the hepatitis B vaccine being 300mg/L – 400mg/L.  
WO/2017/165565A1
Methods for generating synthetic genomes, for example synthetic genomes having desired properties or viable genomes of reduced size, are disclosed. Also disclosed are synthetic genomes produced by the methods disclosed herein and synthet...  
WO/2017/164388A1
The present invention provides information on a mutant xylose isomerase gene and a mutant protein with which it is possible to impart high xylose metabolic capacity to budding yeast. Also provided is a yeast strain having the mutant xylo...  
WO/2017/165320A1
Methods for improving transgene expression in chloroplasts are disclosed along with improved transgenes so produced and methods of use thereof for the treatment of disease. Specifically, the methods comprising analyzing the native sequen...  
WO/2017/164146A1
Provided is a lactic acid bacteria for lactic acid bacteria-fermented soybean foodstuffs, the lactic acid bacteria having a short fermentation period even when used with soybean raw materials, having a broad optimum temperature range, en...  
WO/2017/162092A1
Provided is a hepatitis B treatment vaccine based on an inactivated whole recombinant hansenula cell which expresses HBsAg and HBcAg. An HBsAgVLP and an HBcAgVLP expressed in the recombinant hansenula cell are used as antigens, the amino...  
WO/2017/162669A1
The present invention is directed to the direct application of beneficial or probiotic bacteria to the vaginal niche for maintenance of a healthy vaginal microbiota and to help restore an unbalanced vaginal microbiota. The application is...  
WO/2017/162091A1
A hepatitis B treatment vaccine on the basis of inactivated, fully recombinant Hansenula cells expressing HBsAg. The vaccine is the HBsAg expressed in recombinant Hansenula cells. 108 cells contain 6-10μg HBsAg as an antigen; the vaccin...  
WO/2017/160779A3
The present invention provides a method of detecting one or more Klebsiella species within a sample from a subject, the method comprising: subjecting DNA and/or RNA from the sample to a PCR amplification reaction using primer pairs targe...  
WO/2017/160573A1
Recombinant microorganisms and methods for using the same are disclosed herein for producing biomass or at least one biomolecule. These methods comprise culturing a photosynthetic microorganism that can overexpress a chlorophyllase, and ...  
WO/2017/159461A1
The present invention addresses the problem of providing a feed composition whereby growth of zooplankton is promoted and the survival rate thereof is enhanced, the feed composition also being safe and having minimal environmental effect...  
WO/2017/160042A1
The present application relates to an L-histidine producing Corynebacterium glutamicum variant and a method for producing L-histidine, using the same.  
WO/2017/159647A1
[Problem] To provide a substance and method that are capable of effectively inducing proliferation in bacteria of the genus Faecalibacterium, thereby contributing to the prevention and treatment of diseases such as enterocolitis. [Soluti...  
WO/2017/161196A1
An improved process of cleaning biological tissues containing materials (liquids, blood, proteins, and organic materials) is provided. An improved sterilization process for biological tissues that provides removal of both aerobic (Bacill...  
WO/2017/159795A1
The present invention identifies an enzyme exhibiting activity for synthesizing dihydrotentoxin, which is a precursor for tentoxin, and also identifies an enzyme exhibiting activity for synthesizing tentoxin using dihydrotentoxin as a su...  
WO/2017/156701A1
Provided is a method for screening and culturing a high-yield and low temperature-tolerant Arthrospira and the low temperature-tolerant Arthrospira obtained by this method, wherein the screening culture method comprises chemical mutagene...  
WO/2017/159499A1
A novel microorganism, which is a phosphorus-dissolving bacterium belonging to the genus Pseudomonas and decomposing a hardly soluble phosphorus compound into phosphoric acid, is a mutant defective in the function of PP_4484 protein.  
WO/2017/157593A1
The invention relates to the field of cell culture technology. It concerns the knockdown, using RNA interference, or gene knockout, of activating transcription factor 6 beta (ATF6B), or the combination of ceramide synthase 2 (CERS2) and ...  
WO/2017/157773A1
The present invention generally relates to a method for degrading malodors preferably with regard to the treatment of hard and/or soft surfaces, and more particularly relates to the degradation of malodors in dish washing machines, laund...  
WO/2017/159483A1
The present invention addresses the problem of providing lactic acid bacteria that suppress secondary fermentation of silage and are useful for preferred silage preparation. The present invention also addresses the problem of providing a...  
WO/2017/159643A1
[Problem] To provide: an agent for increasing intestinal butyric acid which is capable of effectively increasing intestinal butyric acid; a food composition for increasing intestinal butyric acid; a proliferation agent for butyric acid-p...  
WO/2017/160801A1
This invention relates to compositions and methods for the production of Type III polyketides using genetically modified oleaginous yeast strains, for example, Yarrowia lipolytica.  
WO/2017/160689A1
The present invention is related to the field of CRISPR-Cas9 gene editing platforms. In particular, the present invention has identified Type II-C Cas9 anti-CRISPR (Acr) inhibitors that control Cas9 gene editing activity. Co-administrati...  
WO/2017/160849A1
Embodiments of the disclosure concern methods and compositions related to a particular immunogenic composition that comprises the Trypanosoma cruzi Tc24 protein having substitutions at four cysteine residues to improve stability and/or d...  
WO/2017/161181A1
Fusion proteins, recombinant Bacillus cereus family members that express fusion proteins, and exosporium fragments derived from spores of the recombinant Bacillus cereus family members are provided. Compositions comprising the spores or ...  
WO/2017/158189A1
The present disclosure relates to the modulation in the RAS/cAMP/PKA signaling pathway for maintaining the propagation efficiency and increasing fermentation efficiency of yeast cells. The present disclosure provides yeast cells having o...  
WO/2017/155803A1
The present disclosure relates to methods for using one or more polypeptides with phytase activity in grain processing, ethanol, and biofuel production.  
WO/2017/155036A1
The present invention provides a light-emitting enzyme protein including an amino acid sequence of SEQ ID NO: 2, and variants thereof.  
WO/2017/154955A1
The present invention is a glucose composition characterized by containing, as equivalents in an aqueous solution of said composition having a glucose concentration of 100 g/L, 0-25 g/L of xylose, 0.1-10 g/L of acetic acid, 0.15-2.0 g/L ...  
WO/2017/154868A1
The present invention provides a composition that can treat cancer by specifically acting on anti-transmembrane protein 180 (TMEM-180), a test method for cancer that includes a step for measuring TMEM-180 in a sample, and an antibody use...  
WO/2017/152273A1
Methods that may be used for the manufacture of a class of chemical compounds known as terpenoid indole alkaloids, including tabersonine and catharanthine are provided. Compositions useful for the synthesis of terpenoid indole alkaloids,...  
WO/2017/154123A1
The purpose of the present invention is to provide: a culture container that, even if the culture container is moved from a space having a high degree of cleanliness to a space having a lower degree of cleanliness, enables culture operat...  
WO/2017/154951A1
Provided is a method for recovering extracellular vesicles having excellent separation efficiency for separating and trapping the extracellular vesicles such as exosomes in a dispersion, the method furthermore making it possible to effic...  
WO/2017/154614A1
The present invention addresses the problem of providing a nanowire device whereby the temperature of a nanowire can be adjusted. The problem addressed by the present invention is solved by a nanowire device including: an insulating subs...  
WO/2017/155101A1
Provided is a greenish yellow fluorescent protein having high pH stability (reduced pH sensitivity). The fluorescent protein in one or a plurality of embodiments has an amino acid sequence in which at least the mutation below is introduc...  
WO/2017/156461A3
The invention relates to fusion proteins comprising an antigen binding domain fused with a modified heat shock 70 protein. The invention further relates to methods of using the fusion proteins to induce an immune response to antigens and...  
WO/2017/156356A1
The present invention is a DNA expression vector comprising: a toxP; a mutant toxO that blocks Fe-mediated regulation of gene expression; and a DNA sequence encoding a protein, wherein the toxP and the mutant toxO regulate expression of ...  

Matches 101 - 150 out of 99,004